Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
At least 40 people die in Kenya after dam collapses
NAIROBI, Kenya (AP) — A dam collapsed in western Kenya early Monday, killing at least 45 people and2024-04-30Black sailor killed at Pearl Harbor FINALLY identified more than eight decades after 19
The remains of a black sailor who died during Japanese attack on Pearl Harbor have finally been iden2024-04-30China's Xiaomi releases its first self
(Xinhua) 08:36, March 29, 2024BEIJING, March 29 (Xinhua) -- Chinese tech firm Xiaomi on Thursday nig2024-04-30- (Ecns.cn) 13:00, March 15, 2024China-Europe Railway Express (CRE) is hailed as the "iron camel carav2024-04-30
- Sir Keir Starmer today lashed out 'absolute chaos' in Scottish politics as Humza Yousaf quit as Firs2024-04-30
China's privately offered funds hit 20.58 trln yuan
(Xinhua) 10:37, February 14, 2024BEIJING, Feb. 12 (Xinhua) -- The value of China's privately offered2024-04-30
atest comment